Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Italian Retrospective and Prospective Observation of Antiretroviral Treatment in Patients Taking DarunavIr/cobicistAt Plus eMtricitabine and Tenofovir AlafeNamide fumaraTE - DIAMANTE

NCT03577470 is registered in ClinicalTrials.gov with Janssen-Cilag S.p.A. as lead sponsor.

NCT NCT03577470
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03577470 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Italian Retrospective and Prospective Observation of Antiretroviral Treatment in Patients Taking DarunavIr/cobicistAt Plus eMtricitabine and Tenofovir AlafeNamide fumaraTE - DIAMANTE
Lead sponsor
Janssen-Cilag S.p.A.
Phase
Observational
Overall status
Completed
Start date
June 13, 2018
Completion date
September 28, 2020
Enrollment
246 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

human immunodeficiency virus (hiv)